MAZE
Maze Therapeutics, Inc.
26.10$
-0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 70.8% | 47.7% | 83.8% | 88.1% | |
| 66.6% | 40.8% | 81.8% | 47.7% | |
| 66.6% | 40.8% | 81.8% | 86.1% | |
| – | – | – | 0.4% | |
| 32.4% | 85.9% | 18.1% | 10.6% | |
| 13.9% | 22.8% | 8.6% | 5.7% | |
| 2.9% | 6.3% | 1.9% | 1.2% | |
| 1.1% | 2.8% | 0.8% | 0.5% | |
| – | 28.1% | – | – | |
| 67.6% | 14.1% | 81.9% | 89.4% | |
| -196.9% | -553.4% | -149.0% | -123.3% | |
| 29.2% | 61.2% | 18.2% | 10.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.